(Q40502315)

21 September 2017

1 reference

title

Efficacy of treatment of osteoporotic fractures (English)

1 reference

21 September 2017

0 references

J A Eisman

1

1 reference

PubMed ID

7709928

21 September 2017

language of work or name

English

0 references

publication date

1 February 1995

1 reference

American Journal of Medicine

21 September 2017

1 reference

21 September 2017

98

1 reference

21 September 2017

2A

1 reference

21 September 2017

17S-23S

1 reference

Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Prediction of osteoporotic fractures by postural instability and bone density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Bone mineral density in elderly men and women: results from the Framingham osteoporosis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Appendicular bone mineral and a woman's lifetime risk of hip fracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Vitamin D3 and calcium to prevent hip fractures in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Spine fracture risk is predicted by non-spine fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Bisphosphonates and vertebral fracture: An epidemiological perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Quality of life and vertebral osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Prevalence and incidence of vertebral deformities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Epidemiology of fractures of the proximal femur in Geneva: Incidence, clinical and social aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Fractures of the proximal femur in Picardy, France, in 1987.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Global public health and the information superhighway. Doctors and students need computer training

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Design of the Fracture Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

The effect of postmenopausal estrogen therapy on bone density in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Effects of nandrolone decanoate on bone mass in established osteoporosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Non-linear increase in vertebral density induced by a synthetic steroid (Org OD 14) in women with established osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Short-term effect of alendronate on bone mass and bone remodeling in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Effects of salmon calcitonin suppositories on bone mass and turnover in established osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Synthetic human calcitonin in postmenopausal osteoporosis: a placebo-controlled, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Effect of different doses of nasal salmon calcitonin on bone mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Treatment of postmenopausal osteoporosis with calcitriol or calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Population screening for low bone mineral density: do non-attenders have a lower risk of osteoporosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

Effect of external hip protectors on hip fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2805%2980040-3

10.1016/S0002-9343(05)80040-3

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

7709928